A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
Status:
Completed
Trial end date:
2019-12-09
Target enrollment:
Participant gender:
Summary
A Randomised, Single-Blind, Placebo-Controlled, Crossover Study to Investigate the Effects of
RIST4721, a Novel CXCR2 Inhibitor, on the Inflammatory Response in Healthy Male Subjects
Using a Standardized Blister Model